T1	intervention 10 47	rapid genetic counselling and testing
T2	eligibility 414 499	Newly diagnosed breast cancer patients with at least a 10% risk of a BRCA1/2 mutation
T3	control 562 575	control group
T4	outcome-Measure 631 674	uptake of direct bilateral mastectomy (BLM)
T5	outcome-Measure 679 730	delayed contralateral prophylactic mastectomy (CPM)
T6	duration 732 753	Between 2008 and 2010
T7	No-of-participants 768 771	265
T8	outcome 874 920	percentage of patients opting for a direct BLM
T9	intervention-value 922 927	14.6%
T10	control-value 950 954	9.2%
T11	outcome 1053 1064	delayed CPM
T12	intervention-value 1066 1070	4.5%
T13	control-value 1093 1097	5.7%
T14	outcome 1284 1304	opted for direct BLM
T15	intervention-value 1245 1247	59
T16	intervention-participants 1255 1258	178
T17	intervention-value 1369 1372	22%
T18	control-value 1376 1380	9.2%
